Optimal Management of ADHD

Andrew J. Cutler, MD, and Rakesh Jain, MD, MPH, discuss current and emerging therapies for the management of attention deficit hyperactivity disorders (ADHD).

EP. 1: Overview of ADHD

March 12th 2021

Andrew J. Cutler, MD, provides an overview of the different presentations of attention deficit hyperactivity disorders (ADHD) and the clinical burden on children and adults.

EP. 2: Impact of ADHD on Quality of Life

March 12th 2021

Rakesh Jain, MD, MPH, comments on factors pre-disposing children and adults to ADHD and the impact of disease on patients’ and caregivers’ quality of life (QoL).

EP. 3: Updates in Diagnostic and Treatment Guidelines for ADHD

March 19th 2021

Updates in the AAP (American Academy of Pediatrics) and SDBP (Society for Developmental and Behavioral Pediatrics) guidelines for the assessment, evaluation, and treatment of ADHD in children and adolescents.

EP. 4: Diagnosis and Testing for ADHD

March 19th 2021

A review of common signs and symptoms prompting testing for ADHD and approaching ADHD diagnosis in adults.

EP. 5: Unmet Needs in ADHD

March 19th 2021

Andrew J. Cutler, MD, and Rakesh Jain, MD, MPH, comment on comorbid psychiatric disorders complicating the diagnostic process for ADHD and review unmet needs.

EP. 6: Non-Pharmacological Therapy in ADHD

March 19th 2021

Andrew J. Cutler, MD, discusses the benefits of cognitive behavior therapy (CBT), exercise, and family therapy for the management of ADHD.

EP. 7: Benefits of a Multimodal Treatment Approach to ADHD

March 19th 2021

Rakesh Jain, MD, MPH, shares his thoughts on the importance of combining pharmacological and non-pharmacological treatments for the management of ADHD.

EP. 8: FDA-Approved Medications for ADHD

March 19th 2021

Andrew J. Cutler, MD, reviews currently available stimulants and nonstimulants as well as their safety and efficacy for the treatment of ADHD.

EP. 9: Approaching ADHD Treatment Selection in Children and Adults

March 19th 2021

Rakesh Jain, MD, MPH, considers the evidence-based recommended hierarchy in the choice of medications for the treatment of pediatric and adult ADHD.

EP. 10: Emerging Treatments for ADHD

March 19th 2021

A discussion on the recent development of investigational serotonin norepinephrine modulating agent (SNMA), SPN-812, for the treatment of ADHD in adults.